随机、双盲、安慰剂对照评价注射用凝血因子X激活剂单次给药在健康志愿者中的安全性和耐受性的Ⅰ期临床研究
[Translation] A randomized, double-blind, placebo-controlled phase I clinical study to evaluate the safety and tolerability of a single dose of factor X activator for injection in healthy volunteers
本试验的目的是评价注射用凝血因子X激活剂单次给药在健康受试者中的安全性、耐受性,并考察其对健康受试者凝血功能的影响
[Translation] The purpose of this study is to evaluate the safety and tolerability of a single dose of factor X activator for injection in healthy subjects and to investigate its effect on coagulation function in healthy subjects.
100 Clinical Results associated with Beijing Nuoweikang Medical Technology Co. Ltd.
0 Patents (Medical) associated with Beijing Nuoweikang Medical Technology Co. Ltd.
100 Deals associated with Beijing Nuoweikang Medical Technology Co. Ltd.
100 Translational Medicine associated with Beijing Nuoweikang Medical Technology Co. Ltd.